INDGNBSEINDEGENE LIMITEDHighNeutral
Announced Mon, 26 Oct, 2026 · 16:28 IST

Indegene incorporates wholly owned Portugal subsidiary

Listed Co AcquisitionStrategic Transactions View source PDFExplain this filing

INDGN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹597.10
prior close
₹601.75
announcement price
After-mkt
timing
Nifty Microcap 250marketpendingvs market: pending
Healthcare Research Analytics & Technology peers, median of 5sector+2.6%-2.7% vs sector

On the reaction day the stock moved 2.7 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+0.0
15m
+0.4
30m
+0.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0pendingpending+2.6-2.7
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indegene Ireland Limited, a wholly owned unit, incorporated Indegene Portugal Unipessoal LDA on 23 October 2026, confirmed on 26 October. The new entity is 100 percent owned, has nil turnover and has not begun operations. No consideration or acquisition cost applies. It will provide life sciences, healthcare, clinical development and related corporate services to establish a presence in Portugal.

Likely market impact

This may support European expansion, but with no operations or revenue yet, the immediate effect on earnings and the share price is likely immaterial.